These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38871090)

  • 1. Dapagliflozin dampens liver fibrosis induced by common bile duct ligation in rats associated with the augmentation of the hepatic Sirt1/AMPK/PGC1α/FoxO1 axis.
    Hassan HA; Nageeb MM; Mohammed HO; Samy W; Fawzy A; Afifi R; Abbas NAT
    Toxicol Appl Pharmacol; 2024 Aug; 489():116991. PubMed ID: 38871090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dapagliflozin attenuates steatosis in livers of high-fat diet-induced mice and oleic acid-treated L02 cells via regulating AMPK/mTOR pathway.
    Luo J; Sun P; Wang Y; Chen Y; Niu Y; Ding Y; Xu N; Zhang Y; Xie W
    Eur J Pharmacol; 2021 Sep; 907():174304. PubMed ID: 34224699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.
    Zhang Y; Lin X; Chu Y; Chen X; Du H; Zhang H; Xu C; Xie H; Ruan Q; Lin J; Liu J; Zeng J; Ma K; Chai D
    Cardiovasc Diabetol; 2021 Jun; 20(1):121. PubMed ID: 34116674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of cilostazol on liver injury induced by common bile duct ligation in rats: Role of SIRT1 signaling pathway.
    Kabil SL
    Clin Exp Pharmacol Physiol; 2018 Dec; 45(12):1341-1350. PubMed ID: 29943424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil protects against bile duct ligation induced hepatic fibrosis in rats: Potential role for silent information regulator 1 (SIRT1).
    Abd El Motteleb DM; Ibrahim IAAE; Elshazly SM
    Toxicol Appl Pharmacol; 2017 Nov; 335():64-71. PubMed ID: 28974454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effects of Chlorella vulgaris on carbon tetrachloride induced liver fibrosis by targeting Hippo signaling pathway and AMPK/FOXO1 axis.
    Mohseni R; Alavian SM; Sadeghabadi ZA; Heiat M
    Mol Biol Rep; 2021 Jan; 48(1):117-126. PubMed ID: 33296068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor.
    Ye Y; Bajaj M; Yang HC; Perez-Polo JR; Birnbaum Y
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):119-132. PubMed ID: 28447181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapagliflozin as an autophagic enhancer via LKB1/AMPK/SIRT1 pathway in ovariectomized/D-galactose Alzheimer's rat model.
    Ibrahim WW; Kamel AS; Wahid A; Abdelkader NF
    Inflammopharmacology; 2022 Dec; 30(6):2505-2520. PubMed ID: 35364737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice.
    Zheng Y; Liu T; Wang Z; Xu Y; Zhang Q; Luo D
    Int J Biol Macromol; 2018 Jun; 112():929-936. PubMed ID: 29447962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
    Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
    J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dapagliflozin attenuates high glucose-induced endothelial cell apoptosis and inflammation through AMPK/SIRT1 activation.
    Faridvand Y; Kazemzadeh H; Vahedian V; Mirzajanzadeh P; Nejabati HR; Safaie N; Maroufi NF; Pezeshkian M; Nouri M; Jodati A
    Clin Exp Pharmacol Physiol; 2022 Jun; 49(6):643-651. PubMed ID: 35274762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dapagliflozin Suppresses ER Stress and Improves Subclinical Myocardial Function in Diabetes: From Bedside to Bench.
    Shih JY; Lin YW; Fisch S; Cheng JT; Kang NW; Hong CS; Chen ZC; Chang WT
    Diabetes; 2021 Jan; 70(1):262-267. PubMed ID: 33115828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced
    Hodrea J; Balogh DB; Hosszu A; Lenart L; Besztercei B; Koszegi S; Sparding N; Genovese F; Wagner LJ; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F1017-F1029. PubMed ID: 32116017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
    Birnbaum Y; Bajaj M; Yang HC; Ye Y
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation.
    Hazem RM; Ibrahim AZ; Ali DA; Moustafa YM
    Int Immunopharmacol; 2022 Mar; 104():108503. PubMed ID: 34998036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
    Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
    J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SGLT2 inhibitor as a potential therapeutic approach in hyperthyroidism-induced cardiopulmonary injury in rats.
    Bastawy N; El-Mosallamy AEMK; Aljuaydi SH; AbuBakr HO; Rasheed RA; Sadek AS; Khattab RT; Abualyamin WB; Abdelaal SE; Boushra AF
    Pflugers Arch; 2024 Jul; 476(7):1125-1143. PubMed ID: 38700719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK-mTOR Interplay.
    Chen H; Tran D; Yang HC; Nylander S; Birnbaum Y; Ye Y
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):443-461. PubMed ID: 32335797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapagliflozin alleviates right heart failure by promoting collagen degradation by reducing ROS levels.
    Liu DD; Liu XL; Zheng TF; Li X; Zhao YC; Pan JC; Yuan C; Wang QQ; Zhang M
    Eur J Pharmacol; 2024 Oct; 981():176875. PubMed ID: 39121982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piceatannol promotes hepatic and renal AMPK/SIRT1/PGC-1α mitochondrial pathway in rats exposed to reserpine or gamma-radiation.
    Mahmoud Moustafa E; Rashed ER; Rashed RR; Omar NN
    Int J Immunopathol Pharmacol; 2021; 35():20587384211016194. PubMed ID: 33985371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.